scholarly article | Q13442814 |
P2093 | author name string | Montplaisir S | |
Sharkawi M | |||
Lagacé J | |||
Omri A | |||
Beaulac C | |||
Bouhajib M | |||
P2860 | cites work | Micro-determination of tobramycin in serum by high-performance liquid chromatography with ultraviolet detection | Q70976303 |
Micro determination of gentamicin in serum by high-performance liquid chromatography with ultraviolet detection | Q71213469 | ||
Controlled delivery of an antitumor drug: localized action of liposome encapsulated cytosine arabinoside administered via the respiratory system | Q71244575 | ||
Endobronchial pH. Relevance of aminoglycoside activity in gram-negative bacillary pneumonia | Q71730810 | ||
Microbiology of cystic fibrosis lung infections: themes and issues | Q72082088 | ||
Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase | Q93589397 | ||
Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis | Q33903005 | ||
Comparative properties and methods of preparation of lipid vesicles (liposomes). | Q34275078 | ||
Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group | Q35248679 | ||
In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa | Q35574121 | ||
Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant | Q35673789 | ||
Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. | Q36407886 | ||
Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. | Q39613399 | ||
A rat model of chronic respiratory infection with Pseudomonas aeruginosa | Q39663990 | ||
Tissue penetration of antibiotics | Q39733571 | ||
Aminoglycoside antibiotics in infectious diseases. An overview | Q39738119 | ||
The influence of vesicle membrane properties on the interaction of lipid vesicles with cultured cells | Q39773523 | ||
Bronchial Tree Penetration of Antibiotics | Q40149327 | ||
The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis | Q40299053 | ||
Penetration of antibiotics into respiratory secretions. | Q40304195 | ||
The Concentration of Tobramycin in Bronchial Secretions | Q41032685 | ||
Lung Uptake of Liposome-entrapped Glutathione After Intratracheal Administration | Q43618690 | ||
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre | Q44021808 | ||
Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? | Q44379999 | ||
The effect of liposomal cefoperazone against Pseudomonas aeruginosa in a granulocytopenic mouse model of acute lung infection | Q44861655 | ||
Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa | Q45137682 | ||
Localization of alveolar surfactant clearance in rabbit lung cells | Q46075856 | ||
Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size | Q47434536 | ||
Pharmacokinetic evaluation of tobramycin in the alveolar lining fluid of the rat after endotracheal administration | Q49121682 | ||
The penetration of aminoglycosides into the alveolar lining fluid of rats. The effect of airway inflammation | Q49125375 | ||
Drug-induced ototoxicity. | Q50605940 | ||
Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro. | Q54375838 | ||
Renal parenchymal accumulation of aminoglycoside antibiotics in rats | Q56983379 | ||
Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey | Q66902144 | ||
Cystic fibrosis | Q67485363 | ||
Disposition of drugs in cystic fibrosis. III. Acetaminophen | Q67781829 | ||
Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa | Q67996392 | ||
Liposomal pulmonary drug delivery. I. In vivo disposition of atropine base in solution and liposomal form following endotracheal instillation to the rabbit lung | Q69681435 | ||
The nephropathy of cystic fibrosis: a human model of chronic nephrotoxicity | Q70480733 | ||
Disposition of liposomal gentamicin following intrabronchial administration in rabbits | Q70590954 | ||
Pulmonary delivery of free and liposomal insulin | Q70618580 | ||
Improved microdetermination of gentamicin and sisomicin in serum by high-performance liquid chromatography with ultraviolet detection | Q70830019 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Pseudomonas aeruginosa | Q31856 |
P304 | page(s) | 1090-1095 | |
P577 | publication date | 1994-05-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa | |
P478 | volume | 38 |